Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Cash from Financing Activities (2019 - 2025)

Historic Cash from Financing Activities for Silo Pharma (SILO) over the last 8 years, with Q3 2025 value amounting to $634922.0.

  • Silo Pharma's Cash from Financing Activities fell 6354.21% to $634922.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 3100.54%. This contributed to the annual value of $3.2 million for FY2024, which is 78806.7% up from last year.
  • Silo Pharma's Cash from Financing Activities amounted to $634922.0 in Q3 2025, which was down 6354.21% from $1.7 million recorded in Q3 2024.
  • In the past 5 years, Silo Pharma's Cash from Financing Activities registered a high of $3.8 million during Q1 2021, and its lowest value of -$194423.0 during Q4 2023.
  • For the 4-year period, Silo Pharma's Cash from Financing Activities averaged around $916311.2, with its median value being $316278.0 (2021).
  • Data for Silo Pharma's Cash from Financing Activities shows a peak YoY increase of 2520978.67% (in 2021) and a maximum YoY decrease of 10011.17% (in 2021) over the last 5 years.
  • Quarter analysis of 4 years shows Silo Pharma's Cash from Financing Activities stood at -$2366.0 in 2021, then tumbled by 8117.37% to -$194423.0 in 2023, then skyrocketed by 995.74% to $1.7 million in 2024, then plummeted by 63.54% to $634922.0 in 2025.
  • Its Cash from Financing Activities was $634922.0 in Q3 2025, compared to $1.7 million in Q3 2024 and $1.6 million in Q2 2024.